Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9408 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9241 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.9013 |
High Similarity |
NPD4380 |
Phase 2 |
0.8882 |
High Similarity |
NPD7054 |
Approved |
0.8827 |
High Similarity |
NPD7472 |
Approved |
0.8827 |
High Similarity |
NPD7074 |
Phase 3 |
0.882 |
High Similarity |
NPD3818 |
Discontinued |
0.879 |
High Similarity |
NPD7075 |
Discontinued |
0.8774 |
High Similarity |
NPD6801 |
Discontinued |
0.8773 |
High Similarity |
NPD6797 |
Phase 2 |
0.872 |
High Similarity |
NPD7251 |
Discontinued |
0.872 |
High Similarity |
NPD6559 |
Discontinued |
0.8718 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8684 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD7808 |
Phase 3 |
0.8599 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8591 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8591 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8554 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8535 |
High Similarity |
NPD1934 |
Approved |
0.8533 |
High Similarity |
NPD1549 |
Phase 2 |
0.8471 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8442 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8428 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8354 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8278 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8258 |
Intermediate Similarity |
NPD6799 |
Approved |
0.825 |
Intermediate Similarity |
NPD2801 |
Approved |
0.825 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8217 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8212 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8199 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8141 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8089 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8067 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8065 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8038 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8024 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7978 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7975 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7961 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7961 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7955 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7892 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7885 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7862 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7862 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7861 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7861 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7826 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7818 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7805 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7798 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7771 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD920 |
Approved |
0.7722 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7722 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7697 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD1091 |
Approved |
0.768 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.765 |
Intermediate Similarity |
NPD6776 |
Approved |
0.765 |
Intermediate Similarity |
NPD6782 |
Approved |
0.765 |
Intermediate Similarity |
NPD6781 |
Approved |
0.765 |
Intermediate Similarity |
NPD6778 |
Approved |
0.765 |
Intermediate Similarity |
NPD6779 |
Approved |
0.765 |
Intermediate Similarity |
NPD6780 |
Approved |
0.765 |
Intermediate Similarity |
NPD6777 |
Approved |
0.764 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7572 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7553 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7547 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7546 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD37 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7527 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD919 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7514 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4966 |
Approved |
0.75 |
Intermediate Similarity |
NPD7583 |
Approved |
0.75 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7473 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7473 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7455 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7435 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7435 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7433 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7433 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7433 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7427 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7405 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7384 |
Intermediate Similarity |
NPD5710 |
Approved |
0.738 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7377 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7377 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7375 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7355 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7348 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7341 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.732 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7258 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7258 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7254 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD943 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.712 |
Intermediate Similarity |
NPD8319 |
Approved |
0.712 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7117 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7105 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7102 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7067 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7049 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7
|
Intermediate Similarity |
NPD3823 |
Discontinued |